What operational progress did ASP Isotopes announce in its recent shareholder letter?

ASP Isotopes announced significant operational progress across its business units, including over 50% organic revenue growth in the first half of 2026 for its PET Labs segment, and that its isotope facilities and Renergen projects are nearing key milestones.

Which specific segments or projects of ASP Isotopes are highlighted as approaching key milestones?

The isotope facilities and Renergen projects are explicitly stated to be nearing key milestones, alongside strong performance from the PET Labs segment, which reported over 50% organic revenue growth in the first half of 2026.

ASP Isotopes says PET Labs, Renergen, isotope facilities nearing key milestones

Aug 4, 2026

ASP Isotopes reported over 50% organic revenue growth for its PET Labs segment in H1 2026, while isotope facilities and Renergen projects approach key milestones ahead of Q2 financial results.

Seeking Alpha

2026-03-31

ASP Isotopes Partners with University of Bristol, Survives Class-Action Lawsuit

2026-04-11

ASP Isotopes Inc Targets Initial Commercial Shipments for Key Isotopes by 2026-2027

2026-04-12

ASP Isotopes Revenue Surge Tests Bullish Growth Narratives Against Deepening Losses

2026-04-13

ASP Isotopes Reports Q4 Revenue Surge Amid Widening Losses

2026-04-13

$333M Cash Backs ASP Isotopes' 2026 Push for First Sales